News

Teva launches SYNCareTM to support patients taking Synribo

BY Ryan Chavis

FRAZER, Pa. — Teva Pharmaceutical on Wednesday announced the launch of SYNCareTM, a program designed to support patients taking Synribo (omacetaxine mepesuccinate) for at-home injection.

Through the program, patients will receive:

  • Home delivery of prepared, prescribed doses;
  • All supplies needed for home administration;
  • Educational and injection training resources; and
  • A 24/7 toll-free hotline number.

Synribo recently received approval from the Food and Drug Administration for at-home administration. Adults with chronic or accelerated phase chronic myeloid leukemia who are no longer responding to (or who were not able to tolerate,) two or more tyrosine kinase inhibitors now have the option of administering the drug at home.

"The comprehensive level of support provided through SYNCare will help my patients administer Synribo in their homes," said Meir Wetzler, M.D., FACP, chief of the leukemia section at Roswell Park Cancer Institute. "With supported home administration, patients living with CML are empowered with flexibility in their treatment regimen."

Teva has entered into an exclusive agreement with Diplomat Pharmacy to distribute Synribo to patients at home, the company said. Diplomat will ensure custom preparation by a healthcare professional of each dose and delivery of Synribo directly to the patient's home.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

CVS Health’s Larry Merlo talks of name change, opportunities in health care on CNBC

BY Antoinette Alexander

WOONSOCKET, R.I. — Shortly after announcing Wednesday morning its corporate name change to CVS Health, CEO Larry Merlo appeared on CNBC to weigh in on the name change and the opportunities to play a greater role in today’s healthcare market, as well as to highlight the fact that its stores are now officially tobacco-free.

“We think about today’s announcement of our corporate name change to CVS Health as really catching up with some of the things that we’ve been doing for the last couple of years. We’ve got a big focus on keeping people adherent and compliant to their prescription medications,” Merlo said Wednesday on CNBC.

“We have many opportunities to play a bigger role in healthcare delivery. We have our 7,700 CVS pharmacies, we have our leading benefit management company and we have walk-in medical clinics now. So, we are doing many things to help change and shape the future of healthcare delivery,” Merlo added.

Meanwhile, the news that CVS Health has now officially ended tobacco sales at its pharmacy locations — nearly a month ahead of the previously targeted date of Oct. 1 — drew accolades from the White House.

“WH applauds CVS for ending sale of tobacco products. WH says it sets “a powerful example that we hope others in the industry will follow,” tweeted CBS News White House correspondent Mark Knoller.

Those who visit the company’s website also will notice the change. Reflecting a new look and feel and the new corporate name, the revamped CVS Health site states on the home page: “Our name has changed, but our purpose remains the same: helping people on their path to better health.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

DSE Healthcare Solutions addresses sensitive bladder health issue with video campaign

BY Michael Johnsen

EDISON, N.J. — DSE Healthcare Solutions recently released an OTC category video campaign under its Cystex brand name that is taking off virally, adressing a topic that doesn’t get a lot of attention because of its sensitive nature — sex and urinary tract infections. 
 
As part of the "Cystex Your Bladder Matters" video series — the campaign promotes good bladder health with the recent release of "Burning Love," a new music video for the brand aiming to help educate women about the sex and UTI connection. 
 
“Shining the light on a sensitive issue, Cystex continues to bring women’s urinary health to the forefront in an approachable and fun manner that consumers can identify with,” said Robin Russo, president Robin Leedy & Associates. “After the success of the Cystex Kegel video, which has more than 52,000 views on YouTube, we came to believe that a direct approach to a fairly niche topic and audience in the video format was effective in reaching UTI sufferers.”  
 
“Cystex is a legacy brand that continues to reinvent itself to resonate with a growing audience,” said Raymond Abrahamsen, VP new products at DSE Healthcare Solutions. “Our goal with the launch of the 'Burning Love' video remains to educate and encourage important discussion of women’s urinary health continuing off the success of our first music video in the series. We’ve worked with RL&A on the Cystex brand for more than five years, and the Your Bladder Matters campaign and videos — which is an integral part of our consumer outreach — have definitely resonated with the target audience with brand sales continuing to climb for the past several years.”    
 
Using an integrated approach with strategized video tactics and promotional efforts via the brand’s social media channels as well as through social influencers, the “Burning Love” music video has garnered almost 50,000 views to date, with a successful completion rate of 85%. “Considering that most YouTube videos have a completion rate of 20%, despite length, 'Burning Love' has already proven to hit home with the brand’s target audience once again,” Russo said.
 
Check out the video at www.youtube.com/cystexvideoseries.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?